Carsten Haagen Nielsen

Carsten Haagen Nielsen

Guest Researcher


Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2022
  2. Published

    Combination of [177Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model

    Simón, M., Jørgensen, Jesper Tranekjær, Khare, Harshvardhan, Christensen, Camilla Hell, Nielsen, Carsten Haagen & Kjær, Andreas, 2022, In: Pharmaceutics. 14, 6, p. 1-16 1284.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic

    Loft, Mathias Hougaard, Christensen, C., Clausen, Malene Martini, Carlsen, Esben Andreas, Hansen, C. P., Kroman, Niels Thorndahl, Langer, Seppo W., Høgdall, Claus Kim, Madsen, J., Gillings, N., Nielsen, Carsten Haagen, Klausen, Thomas Levin, Holm, S., Loft, A., Berthelsen, A. K. & Kjær, Andreas, 2022, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 12, p. 1871-1879

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    PET in vivo generators 134Ce and 140Nd on an internalizing monoclonal antibody probe

    Severin, G. W., Fonslet, J., Kristensen, L. K., Nielsen, Carsten Haagen, Jensen, A. I., Kjær, Andreas, Mazar, A. P., Johnston, K. & Köster, U., 2022, In: Scientific Reports. 12, 1, 7 p., 3863.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 32363418